Kelly Holman is a Managing Director at Genesys Capital, whose known portfolio counts 11 companies.
Is Kelly Holman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcareSaaS
Contacts
Affiliated funds' portfolios
Managing Director at Genesys Capital, whose known portfolio counts 11 companies
- Flosonics
- Cresta
- Limitless
- Veralox Therapeutics
- Feldan Therapeutics
- Giiant Pharma
- IDbyDNA
- Inversago Pharma
- Echopass
- Enspire DBS Therapy
- Scaled Cognition
Investor Profile
Kelly Holman is listed against sectors AI, Healthcare and SaaS, and focus areas AI Agents, Bioinformatics, Biotech and CRM in the database.
Genesys Capital appears in Growth, Seed and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Kelly Holman is worth approaching.
Colleagues at Genesys Capital
Andrew McInnes
Investor
Boston, United States
Joerg Feldmann
Genesys Solution Partner
Cologne, Germany
Jennifer Williams
Partner and CFO
Toronto, Canada
Ryan Lanpher
Director
San Francisco, United States
Karthika PM
Manager
Chennai, India
Jamie Stiff
Managing Director
Toronto, Canada
Damian Lamb
Managing Director
Toronto, Canada
Danielle Cox
Investor
Erlanger, United States
Alex Ball
Investor
Washington, United States
Matt Martell
Investor
Phoenix, United States
Gonzalo Miranda
Board Member
Chile
Frequently asked questions
Who is Kelly Holman?
Kelly Holman is a corporate venture investor and venture capital investor based in Toronto, Ontario, Canada, listed as Managing Director at Genesys Capital. The known portfolio of that firm counts 11 companies. That portfolio belongs to the firm, not to Kelly Holman personally.
What does Kelly Holman invest in?
Listed sectors include AI, Healthcare and SaaS; listed focus areas include AI Agents, Bioinformatics, Biotech and CRM. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kelly Holman invest at?
Genesys Capital appears in Growth, Seed and Series A rounds across its known deals, and Kelly Holman is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kelly Holman listed at?
Kelly Holman is listed as Managing Director at Genesys Capital. 11 other people in the database share a firm with Kelly Holman.
How do I contact Kelly Holman?
An email address, a phone number and a LinkedIn page are on file for Kelly Holman. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal